Lunai Bioworks (LNAI) Total Debt Growth (1y) (2012 - 2022)
Lunai Bioworks (LNAI) Total Debt Growth (1y) (2012 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.10% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 12.42% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -57.72% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 3.78% |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -0.03% |
| Jun 30, 2022 | -0.04% |
| Sep 30, 2021 | -37.20% |
| Jun 30, 2021 | -41.02% |
| Mar 31, 2021 | 14.47% |
| Dec 31, 2020 | 57.47% |
| Sep 30, 2020 | 37.24% |
| Jun 30, 2020 | 36.99% |
| Mar 31, 2020 | -72.65% |
| Dec 31, 2019 | -81.71% |
| Sep 30, 2019 | -74.80% |
| Jun 30, 2019 | -75.24% |
| Dec 31, 2013 | -95.42% |
| Sep 30, 2013 | 0.00% |
| Mar 31, 2013 | 71.96% |
| Dec 31, 2012 | 4,739.11% |
| Sep 30, 2012 | 178.38% |